Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, Inc. (KURA), sold 9,078 shares at $11.18 ($101K) on 2025-11-14, disclosed to the SEC on 2025-11-14.
Open-market sale of $101k KURA by SVP, Finance & Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.18 | 4,539 | $51K | 50.0% |
| 2 | $11.18 | 4,539 | $51K | 50.0% |
| Total | $11.18 avg | 9,078 | $101K | 100% |
| Filing → |
| KURA | SELL | 2025-09-29 | $41K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |
| KURA | SELL | 2024-01-31 | $41K | — | Filing → |